Welcome to the CENTOGENE Booth
Explore our latest innovations to guide precision medicine and get ⇢ direct access to key materials right from this page or get to know ⇢ our team on side.
Meet Our Scientific Team @Booth #348
Victor Llinares
Chief Commercial Officer
Krishna Kumar Kandaswamy
Chief Technology Officer
Alejandro Rincon
Chief Operating Officer
Bruno Coprerski
Chief Operating Officer Brazil
Andy Chang
Chief Executive Officer, Asia Pacific
Ricardo Noble
Managing Director Mexico
Jorge Pinto-Basto
VP Medical Genetics
Nasser Al-Asmar
VP Scientific and Medical Affairs
Diego Marin
VP Scientific Affairs Reproductive Health North America
Jose Ignacio Pineiro
VP Global Supply Chain
Ana Esteban
VP Marketing & Customer Experience
Luis Aznar
VP Sales South Europe
Eleni Perraki
Senior Product Manager
Gisela Maggiotto
Scientific Advisor & Senior Embryologist
Alvaro Jimenez
Regional Genetics Sales Director – Spain & Portugal
Edel Rocher
BD Director – Reproductive Health, Western Europe
Emily Liang
General Manager, North East Asia
Dawood Dudekula
General Manager South Asia
Alissa Magwood
Country Manager Canada
Martin Shumanov
Head of Sales Northern Europe
Lova Satyanarayana Matsa
Clinical Genetic Liaison & Lab Director UAE / Sales Manager
Georges Harb
Sales Manager – Reproductive Genetics (MEA region)
Enrique Martinez de Vallejo
Marketing Specialist
Customizable testing solution that enables physicians to have the flexibility to create a gene panel tailored to each patient’s clinical needs. #YourPatientYourChoice
Whole Genome Sequencing (WGS), offers the most comprehensive one-step solution with the highest diagnostic yield
Whole Exome Sequencing (WES) enables quicker and cost-effective diagnosis for patients with complex and unclear symptoms
Multiomics give a deeper understanding of human biological processes and acts as a unique and highly effective tool for early diagnosis
Our NGS panel portfolio tests for a wide selection of hereditary genetic conditions offering a fast, thorough, and cost-effective diagnostic tool for patients with distinctive clinical features.
Non-invasive prenatal test (NIPT) that screens for the most common fetal chromosomal abnormalities – combining the latest NGS technology with expert medical reporting.
